$126M Beagle Experiment Scandal: Congress Reacts

A large gathering of officials in a congressional chamber during a legislative session

Republican Congressman demands federal health officials immediately cut off funding to a Wisconsin facility after watchdog groups exposed $126 million in taxpayer money financing painful experiments on beagles, sparking outrage among fiscal conservatives and animal welfare advocates alike.

Story Snapshot

Rep. Nicholas Langworthy calls for HHS to defund Ridglan Farms following White Coat Waste Project’s exposé of $126M in taxpayer-funded “maximum pain” experiments on beagles
Animal rescue groups finalized agreement to acquire all 1,500 beagles from the Wisconsin breeding facility, signaling its closure
Federal data shows approximately 50,000 dogs used annually in laboratory testing across the United States
HHS Secretary Robert F. Kennedy Jr. collaborating with rescue organizations to accelerate drawdown of animal testing programs

Taxpayer Dollars Funding Controversial Experiments

White Coat Waste Project revealed that $126 million in federal funds from the Department of Health and Human Services and National Institutes of Health supported experiments on beagles bred at Ridglan Farms in Blue Mounds, Wisconsin. The watchdog organization characterized these procedures as causing “maximum pain” to the animals. Rep. Nicholas Langworthy responded by demanding HHS immediately terminate all funding relationships with the facility, framing the issue as both fiscal irresponsibility and animal cruelty funded by hardworking American taxpayers.

Rescue Agreement Signals Facility Shutdown

On April 30, 2026, the Center for a Humane Economy and Big Dog Ranch Rescue announced they finalized an agreement to acquire all 1,500 beagles remaining at Ridglan Farms. Big Dog Ranch Rescue will rehome approximately 1,000 dogs nationally, while 500 will remain in Wisconsin for adoption through partners including Dane County Humane Society, Beagle Freedom Project, and Wisconsin Puppy Mill Project. The rescue organizations describe the acquisition as part of a larger national trend to phase out beagles and primates from laboratory research programs they label as archaic and unnecessarily painful.

Broader Push Against Government-Funded Animal Testing

The Ridglan controversy fits into a growing bipartisan concern about federal spending on animal research programs. USDA data confirms approximately 50,000 dogs undergo laboratory testing annually in the United States, primarily for drug development purposes. Animal welfare advocates argue many of these experiments represent wasteful government spending on outdated research methods when alternative testing technologies exist. This perspective resonates with fiscal conservatives frustrated by what they perceive as bloated federal budgets funding programs that lack proper oversight and accountability to taxpayers who foot the bill.

Kennedy Involvement Signals Policy Shift

HHS Secretary Robert F. Kennedy Jr.’s collaboration with rescue organizations to “speed drawdown” of animal testing programs indicates a potential policy realignment within the Trump administration. Advocacy groups have called on NIH to halt all funding for beagle and primate experiments and ban primate imports for research purposes. This development highlights an unusual alliance between traditional conservatives concerned about government waste and animal welfare advocates pushing for research alternatives. Whether this coalition can overcome entrenched institutional interests in the biomedical research establishment remains uncertain, but the Ridglan closure represents a tangible victory for those demanding transparency and accountability in federal spending.

The rescued beagles will undergo medical treatment and socialization before being placed for adoption with families across the country. For many Americans tired of watching their tax dollars fund questionable government programs, this story illustrates how citizen advocacy and congressional oversight can force change even in agencies long resistant to outside scrutiny. The question now is whether this represents an isolated incident or the beginning of meaningful reforms to how federal health agencies allocate billions in research funding.